Thoughts on aneuploidy

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 75, Issue , 2010, Pages 445-451

  Torres, E M ^a   Williams, B R ^a   Tang, Y C ^a   Amon, A ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; HEAT SHOCK PROTEIN 70; PROTEIN P53; TRICARBOXYLIC ACID;

ANEUPLOIDY; ARTICLE; AUTOPHAGY; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRESS; CHROMOSOME; CHROMOSOME 21; DISEASE ASSOCIATION; DISOMY; ENERGY; FIBROBLAST; GENE MUTATION; NEOPLASM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN QUALITY; PROTEIN SYNTHESIS; STRESS; YEAST; YEAST CELL; CELL FUNCTION; HUMAN; STOICHIOMETRY;

ANEUPLOIDY; ANIMALS; CHROMOSOMES; CYCLOHEXIMIDE; MICE; MODELS, BIOLOGICAL; NEOPLASMS; PHENOTYPE; PRECANCEROUS CONDITIONS; SACCHAROMYCES CEREVISIAE;

EID: 80052406206     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2010.75.025     Document Type: Article

References (51)

1. Agrawal MG, Bowman LH. 1987. Transcriptional and translational regulation of ribosomal protein formation during mouse myoblast differentiation. J Biol Chem 262: 4868-4875.
2. Albertson DG, Collins C, McCormick F, Gray JW. 2003. Chromosome aberrations in solid tumors. Nat Genet 34: 369-376.
3. Antonarakis SE, Lyle R, Dermitzakis ET, Reymond A, Deutsch S. 2004. Chromosome 21 and Down syndrome: From genomics to pathophysiology. Nat Rev Genet 5: 725-738.
4. Bachurski CJ, Theodorakis NG, Coulson RM, Cleveland DW. 1994. An amino-terminal tetrapeptide specifies cotranslational degradation of β-tubulin but not α-tubulin mRNAs. Mol Cell Biol 14: 4076-4086.
5. Baker DJ, Jeganathan KB, Cameron JD, Thompson M, Juneja S, Kopecka A, Kumar R, Jenkins RB, de Groen PC, Roche P, et al. 2004. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet 36: 744-749.
6. Baker DJ, Jin F, Jeganathan KB, van Deursen JM. 2009. Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity. Cancer Cell 16: 475-486.
7. Benaroudj N, Zwickl P, Seemuller E, Baumeister W, Goldberg AL. 2003. ATP hydrolysis by the proteasome regulatory complex PAN serves multiple functions in protein degradation. Mol Cell 11: 69-78.
8. Bomme L, Bardi G, Pandis N, Fenger C, Kronborg O, Heim S. 1998. Cytogenetic analysis of colorectal adenomas: Karyotypic comparisons of synchronous tumors. Cancer Genet Cytogenet 106: 66-71.
9. Bomme L, Lothe RA, Bardi G, Fenger C, Kronborg O, Heim S. 2001. Assessments of clonal composition of colorectal adenomas by FISH analysis of chromosomes 1, 7, 13 and 20. Int J Cancer 92: 816-823.
10. Bukau B, Weissman J, Horwich A. 2006. Molecular chaperones and protein quality control. Cell 125: 443-451.
11. Bunz F, Fauth C, Speicher MR, Dutriaux A, Sedivy JM, Kinzler KW, Vogelstein B, Lengauer C. 2002. Targeted inactivation of p53 in human cells does not result in aneuploidy. Cancer Res 62: 1129-1133.
12. Caplan AJ, Mandal AK, Theodoraki MA. 2007. Molecular chaperones and protein kinase quality control. Trends Cell Biol 17: 87-92.
13. DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, Thompson CB. 2007. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci 104: 19345-19350.
14. Drapier D, Rimbault B, Vallon O, Wollman FA, Choquet Y. 2007. Intertwined translational regulations set uneven stoichiometry of chloroplast ATP synthase subunits. EMBO J 26: 3581-3591.
15. Edlund T, Normark S. 1981. Recombination between short DNA homologies causes tandem duplication. Nature 292: 269-271.
16. elBaradi TT, van der Sande CA, Mager WH, Raue HA, Planta RJ. 1986. The cellular level of yeast ribosomal protein L25 is controlled principally by rapid degradation of excess protein. Curr Genet 10: 733-739.
17. Gunjan A, Verreault A. 2003. A Rad53 kinase-dependent surveillance mechanism that regulates histone protein levels in S. cerevisiae. Cell 115: 537-549.
18. Hanna J, Leggett DS, Finley D. 2003. Ubiquitin depletion as a key mediator of toxicity by translational inhibitors. Mol Cell Biol 23: 9251-9261.
19. Hasle H, Clemmensen IH, Mikkelsen M. 2000. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 355: 165-169.
20. Hodgkin J. 2005. Karyotype, ploidy, and gene dosage. WormBook 2005: 1-9.
21. Iwanaga Y, Chi YH, Miyazato A, Sheleg S, Haller K, Peloponese JM, Jr, Li Y, Ward JM, Benezra R, Jeang KT. 2007. Heterozygous deletion of mitotic arrest-deficient protein 1 (MAD1) increases the incidence of tumors in mice. Cancer Res 67: 160- 166.
22. Jeganathan K, Malureanu L, Baker DJ, Abraham SC, van Deursen JM. 2007. Bub1 mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis. J Cell Biol 179: 255-267.
23. Kaizu K, Moriya H, Kitano H. 2010. Fragilities caused by dosage imbalance in regulation of the budding yeast cell cycle. PLoS Genet 6: e1000919.
24. Katz W, Weinstein B, Solomon F. 1990. Regulation of tubulin levels and microtubule assembly in Saccharomyces cerevisiae: Consequences of altered tubulin gene copy number. Mol Cell Biol 10: 5286-5294.
25. Larson PS, de las Morenas A, Cerda SR, Bennett SR, Cupples LA, Rosenberg CL. 2006. Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors. J Pathol 209: 307-316.
26. Libuda DE, Winston F. 2006. Amplification of histone genes by circular chromosome formation in Saccharomyces cerevisiae. Nature 443: 1003-1007.
27. Lin HY, Lin SP, Chen YJ, Hung HY, Kao HA, Hsu CH, Chen MR, Chang JH, Ho CS, Huang FY, et al. 2006. Clinical characteristics and survival of trisomy 18 in a medical center in Taipei, 1988-2004. Am J Med Genet A 140: 945-951.
28. Lindsley DL, Sandler L, Baker BS, Carpenter AT, Denell RE, Hall JC, Jacobs PA, Miklos GL, Davis BK, Gethmann RC, et al. 1972. Segmental aneuploidy and the genetic gross structure of the Drosophila genome. Genetics 71: 157-184.
29. Liu H, Krizek J, Bretscher A. 1992. Construction of a GAL1-regulated yeast cDNA expression library and its application to the identification of genes whose overexpression causes lethality in yeast. Genetics 132: 665-673.
30. Maicas E, Pluthero FG, Friesen JD. 1988. The accumulation of three yeast ribosomal proteins under conditions of excess mRNA is determined primarily by fast protein decay. Mol Cell Biol 8: 169-175.
31. Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W, Dobles M, Sorger PK, Murty VV, Benezra R. 2001. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 409: 355-359.
32. Mihaylova VT, Bindra RS, Yuan J, Campisi D, Narayanan L, Jensen R, Giordano F, Johnson RS, Rockwell S, Glazer PM. 2003. Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Mol Cell Biol 23: 3265-3273.
33. Moerman P, Fryns JP, van der Steen K, Kleczkowska A, Lauweryns J. 1988. The pathology of trisomy 13 syndrome. A study of 12 cases. Hum Genet 80: 349-356.
34. Niwa O, Tange Y, Kurabayashi A. 2006. Growth arrest and chromosome instability in aneuploid yeast. Yeast 23: 937-950.
35. Nover L. 1991. Heat shock response. CRC, Boca Raton, FL.
36. Ponder RG, Fonville NC, Rosenberg SM. 2005. A switch from high-fidelity to error-prone DNA double-strand break repair underlies stress-induced mutation. Mol Cell 19: 791-804.
37. Satge D, Sasco AJ, Lacour B. 2003. Are solid tumours different in children with Down's syndrome? Int J Cancer 106: 297-298.
38. Schatz PJ, Solomon F, Botstein D. 1988. Isolation and characterization of conditional-lethal mutations in the TUB1 α-tubulin gene of the yeast Saccharomyces cerevisiae. Genetics 120: 681-695.
39. Segal DJ, McCoy EE. 1974. Studies on Down's syndrome in tissue culture. I. Growth rates and protein contents of fibroblast cultures. J Cell Physiol 83: 85-90.
40. Shih IM, Wang TL, Traverso G, Romans K, Hamilton SR, Ben-Sasson S, Kinzler KW, Vogelstein B. 2001. Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci 98: 2640-2645.
41. Sotillo R, Hernando E, Diaz-Rodriguez E, Teruya-Feldstein J, Cordon-Cardo C, Lowe SW, Benezra R. 2007. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 11: 9-23.
42. Straub T, Becker PB. 2007. Dosage compensation: The beginning and end of generalization. Nat Rev Genet 8: 47-57.
43. Sung HM, Yeamans G, Ross CA, Yasbin RE. 2003. Roles of YqjH and YqjW, homologs of the Escherichia coli UmuC/DinB or Y superfamily of DNA polymerases, in stationary-phase mutagenesis and UV-induced mutagenesis of Bacillus subtilis. J Bacteriol 185: 2153-2160.
44. Sussan TE, Yang A, Li F, Ostrowski MC, Reeves RH. 2008. Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome. Nature 451: 73-75.
45. Theodorakis NG, Cleveland DW. 1992. Physical evidence for cotranslational regulation of β-tubulin mRNA degradation. Mol Cell Biol 12: 791-799.
46. Thompson SL, Compton DA. 2008. Examining the link between chromosomal instability and aneuploidy in human cells. J Cell Biol 180: 665-672.
47. Torres EM, Sokolsky T, Tucker CM, Chan LY, Boselli M, Dunham MJ, Amon A. 2007. Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 317: 916-924.
48. Torres EM, Williams BR, Amon A. 2008. Aneuploidy: Cells losing their balance. Genetics 179: 737-746.
49. Weaver BA, Silk AD, Montagna C, Verdier-Pinard P, Cleveland DW. 2007. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11: 25-36.
50. Williams BR, Amon A. 2009. Aneuploidy: Cancer's fatal flaw? Cancer Res 69: 5289-5291.
51. Williams BR, Prabhu VR, Hunter KE, Glazier CM, Whittaker CA, Housman DE, Amon A. 2008. Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science 322: 703-709.